Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
16.78
+0.06 (0.36%)
Jun 1, 2026, 1:42 PM EDT - Market open
Caris Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 821.15 | 797.8 | 65.44 | 60.01 | 111.14 |
Short-Term Investments | 2.32 | 2.3 | 2.2 | 65.18 | 302.43 |
Cash & Short-Term Investments | 823.46 | 800.09 | 67.64 | 125.19 | 413.57 |
Cash Growth | 2257.53% | 1082.82% | -45.97% | -69.73% | - |
Accounts Receivable | 90.52 | 112.14 | 88.24 | 55.3 | 40.23 |
Inventory | 76.29 | 63.63 | 39.57 | 49 | 46.96 |
Other Current Assets | 23.91 | 21.94 | 20.27 | 13.12 | 15.29 |
Total Current Assets | 1,014 | 997.8 | 215.73 | 242.61 | 516.04 |
Net Property, Plant & Equipment | 82.67 | 63.17 | 67.82 | 107.09 | 138.05 |
Goodwill | 19.34 | 19.34 | 19.34 | 19.34 | 19.34 |
Other Long-Term Assets | 46.2 | 45.35 | 40.84 | 43.86 | 43.99 |
Total Assets | 1,162 | 1,126 | 343.73 | 412.9 | 717.42 |
Accounts Payable | 69.8 | 39.21 | 27.79 | 26.68 | 27.27 |
Accrued Expenses | 73.92 | 87.77 | 77.54 | 68.29 | 56.85 |
Current Portion of Long-Term Debt | 0.17 | 0.17 | 60.09 | 0.17 | 52.79 |
Total Current Liabilities | 143.9 | 127.15 | 165.42 | 95.14 | 136.91 |
Long-Term Debt | 381.4 | 378.82 | 319.44 | 166.42 | 169.57 |
Other Long-Term Liabilities | 43.6 | 42.39 | 136.06 | 171.01 | 158.88 |
Total Long-Term Liabilities | 425 | 421.21 | 455.5 | 337.43 | 328.46 |
Total Liabilities | 568.9 | 548.36 | 620.92 | 432.57 | 465.36 |
Common Stock | 0.28 | 0.28 | 0.04 | 0.04 | 0.14 |
Treasury Stock | -16.9 | -16.9 | -0.33 | -0.33 | -0.33 |
Additional Paid-in Capital | 3,158 | 3,142 | -26.46 | -25.7 | -24.97 |
Accumulated Other Comprehensive Income | - | - | 0.21 | 0.22 | 1.7 |
Retained Earnings | - | - | -2,472 | -2,119 | -1,679 |
Total Common Shareholders' Equity | 3,142 | 3,125 | -2,499 | -2,145 | -1,702 |
Minority Interest | - | - | 2,222 | 2,125 | 1,954 |
Shareholders' Equity | 3,142 | 3,125 | -277.19 | -19.67 | 252.06 |
Total Liabilities & Equity | 1,162 | 1,126 | 343.73 | 412.9 | 717.42 |
Total Debt | 381.58 | 378.99 | 379.53 | 166.59 | 222.36 |
Net Cash (Debt) | 441.89 | 421.1 | -311.89 | -41.4 | 191.21 |
Net Cash Growth | 4.94% | - | - | - | - |
Net Cash Per Share | 1.88 | 2.52 | -8.79 | -1.19 | 5730.69 |
Book Value | 3,142 | 3,125 | -2,499 | -2,145 | -1,702 |
Book Value Per Share | 13.36 | 18.69 | -70.40 | -61.38 | -51013.80 |
Tangible Book Value | 3,123 | 3,106 | -2,518 | -2,164 | -1,721 |
Tangible Book Value Per Share | 13.28 | 18.57 | -70.94 | -61.94 | -51593.50 |